To test the number of Circulating Tumor Cells (CTC) captured by the OncoDiscover Liquid Biopsy in peripheral blood samples of Head and Neck cancer patients.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Confirmed diagnosis of stage 2-4 Head and Neck Cancer
- Registration Number
- CTRI/2018/03/012905
- Lead Sponsor
- Actorius Innovations and Research Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Males or Females.
2. Age > 18 years of age.
3. Written informed consent obtained.
• Confirmed diagnosis of stage 2-4 Head and Neck, (OR) no prior history of cancer.
• Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients.
• Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject.
Exclusion Criteria
1. Patients unable to understand the research protocol and/or provide informed consent.
2. Patients with known immunodeficiency, or pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method